Benign prostatic hyperplasia
Conditions
Interventions
Sham electroacupuncture group:Sham electroacupuncture & Yijin Jing Exercise
Electroacupuncture group:Electroacupuncture & Yijin Jing Exercise
Control group:Yijin Jing Exercise
Sponsors
Hubei Provincial Hospital of TCM
Eligibility
Sex/Gender
Male
Age
50 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1) Meet the Western medical diagnostic criteria established in the "Guidelines for the Multidisciplinary Diagnosis and Treatment of Benign Prostatic Hyperplasia with Integrated Traditional Chinese and Western Medicine (2022 Edition)"; 2) International Prostate Symptom Score (I-PSS) between 8-19 points (inclusive; moderate symptoms); 3) Age between 50 and 70 years; 4) Ultrasound findings indicative of prostatic hyperplasia; 5) Conform to the TCM syndrome differentiation pattern of kidney qi deficiency syndrome; 6) Voluntary participation with signed informed consent form. Note: Only patients fulfilling all six criteria above will be eligible for inclusion in this study.
Exclusion criteria
Exclusion criteria: 1) Patients with concurrent urinary tract infection; 2) Patients with severe bone and joint diseases or muscular disorders; 3) Patients who have received other disease-related treatments that may interfere with the observation of efficacy indicators in this study; 4) Patients exhibiting voiding dysfunction symptoms caused by other pathologies; 5) Patients with significant organic lesions (e.g. neurological diseases bladder urethral or anal disorders) psychiatric disorders intellectual disabilities or those with failed surgical treatments for benign prostatic hyperplasia; 6) Patients with severe cardiovascular cerebrovascular hepatic or renal diseases; 7) Patients with a history of alcohol or substance abuse; 8) Patients requiring prohibited medications that may affect therapeutic efficacy before or during treatment; 9) Patients with non-compliant treatment regimens undeterminable therapeutic outcomes or incomplete data affecting efficacy evaluation. Note: Individuals meeting any of the above criteria are ineligible to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| International Prostate Symptom Score (I-PSS);Maximum Urinary Flow Rate (Uroflowmetry); | — |
Secondary
| Measure | Time frame |
|---|---|
| chinese medicine syndrome scores;Residual Urine Volume;Quality of life Score; | — |
Countries
China
Contacts
Public ContactWei Dan
Hubei Provincial Hospital of TCM
Outcome results
None listed